Use of antagonists of the CB1 receptor for the manufacture of a composition useful for the treatment of hepatic diseases

Details for Australian Patent Application No. 2005218937 (hide)

International Classifications

Event Publications

7 September 2006 PCT application entered the National Phase

PCT publication WO2005/084652 Priority application(s): WO2005/084652

7 July 2011 Application Accepted

Published as AU-B-2005218937

20 October 2011 Alteration of Name

The name of the applicant has been altered to Sanofi; Institut National de la Sante et de la Recherche Medicale (INSERM)

3 November 2011 Standard Patent Sealed

4 October 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.